Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel TbSADH mutants enable high-yield synthesis of chiral biaryl alcohols. Efficient biocatalysis for pharmaceutical intermediates with superior stereoselectivity.
Patent CN114736882B reveals high-efficiency biocatalysis for antiviral intermediates. Offers supply chain stability and cost reduction in API manufacturing without heavy metals.
Patent CN102993256B reveals mild ammonium salt method for selective sugar deprotection. Enhances supply chain reliability and reduces manufacturing complexity significantly.
Patent CN106496193A enables high-purity nilotinib synthesis with superior yield and scalable production for global pharmaceutical supply chains and cost efficiency.
Novel aminotransferase mutants enable high-yield sitagliptin synthesis. Cost-effective, scalable pharma intermediate solution with >99% ee.
Novel Ti-catalyzed method offers mild conditions and high yields for beta-aminocarboxylate production, ensuring cost-effective supply chain solutions.
Patent CN115611961A reveals a mild elimination route for Cholic Acid Intermediate A2, enabling virus-free API production with scalable supply chain advantages.
Novel transaminase mutant enables high-yield sitagliptin intermediate synthesis with superior stereoselectivity and scalable biocatalytic process efficiency for global supply.
Discover a novel bromfenac sodium synthesis method avoiding indole impurities. Enhanced purity, stable pH, and scalable production for pharmaceutical supply chains.
Patent CN115611961A details a novel chemical synthesis for Cholic Acid Intermediate A2, offering a virus-free alternative to animal extraction with scalable manufacturing capabilities.
Novel cobalt-catalyzed synthesis of indole alkaloids offering high yield and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN109825849A reveals a metal-free electrochemical route for trifluoromethyl vinylic compounds, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel LiOH and DMSO hydrolysis method ensures high purity Bempedoic acid intermediate with reduced safety risks and scalable production capabilities for global supply chains.
Patent CN116396950B reveals novel carboxylesterase mutants for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel three-step synthesis for Ramelteon intermediate ensures high yield and eco-friendly production. Reliable pharmaceutical intermediate supplier for global scale-up and cost reduction.
Novel three-step synthesis for ramelteon intermediate ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN113200993A details a novel metal-free synthesis of oxindole spirodihydrofurans using organocatalysis and iodine, offering cost-effective API intermediate manufacturing.
Patent CN121472200A reveals high-efficiency nitrilase mutant for chiral acid synthesis. Offers green manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN111943930A reveals a mild copper-catalyzed route for Lasmiditan. This process eliminates noble metals, offering significant cost reduction and scalable manufacturing for API intermediates.